Skip to main content
Fig. 2 | Acta Neuropathologica Communications

Fig. 2

From: Different curcumin forms selectively bind fibrillar amyloid beta in post mortem Alzheimer’s disease brains: Implications for in-vivo diagnostics

Fig. 2

Co-labelling using curcumin and anti-amyloid beta (Aβ) in Alzheimer brains. Curcumin co-labelling with anti-amyloid-beta using IC-16 in Alzheimer brains (hippocampus (a-c), temporal cortex(d-i), occipital cortex(j-l)) to show overlap and differences. Scale bars 100 μm. Abbreviations: CAA = cerebral amyloid angiopathy, DAPI = 4′,6-diamidino-2-fenylindole

Back to article page
\